Challenges Of Covid 19 Research

By Author: Central BioHub
Total Articles: 113
Comment this article

Use of COVID-19 biospecimens in research
As we know, COVID-19, caused by a mutated strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of fatalities and death since 2019. As a result, on the 30th of January 2020, the World Health Organization (WHO) officially declared COVID-19 a public health emergency of international significance based on the extent and seriousness of the disease. At the same time, at the global level, researchers work day and night on COVID-19 biospecimens collected from suspected or clinically confirmed patients to discover definitive treatments and more sensitive diagnostics devices for better management of the global pandemic.
COVID-19 biospecimens are the wide variety of human samples collected from those who are suspected or tested positive for SARS-CoV-2 infection. It includes serum, plasma, whole blood, oropharyngeal, and nasopharyngeal secretions tested for SARS-CoV-2 antibodies or antigens. Left-over samples after diagnosis are gathered, processed, and stored in cutting-edge biobanks and used as in-vitro human COVID-19 infection models for scientific ...
... studies.

Challenges of COVID-19 research.
Because of the continously rising number of COVID-19 cases worldwide, it is necessary to expand more research to better understand more about pathophysiology and biology of the SARS-CoV-2 infection. Studies on human biospecimens from COVID-19 patients may help the researchers to gain a deeper knowledge of the infection pathophysiology. However, there are numerous risks and challenges involved in the research using COVID-19 biospecimens, Which include:

● Uncertain sample quality: In most situations, research specimens obtained through brokers or biospecimen companies may fail to provide the certification of the chain of custody, biobanking, and collecting of human biospecimens. Therefore, it can raise a question on the quality and authenticity of the research samples may have a direct impact on the research conclusion and validity since it is crucial for the researchers to confirm the sample's legitimacy and approval from the IRB process.
● Accuracy of sample information: For any research on human biospecimens, it is essential to have relevant information such as clinical evaluation details, laboratory investigation reports, and patient demographics to have better characterization and in-depth analysis of research samples. Sometimes, the specimen source provides inaccurate or uncertified information by a qualified medical practitioner. It thus does not comply with the IRB protocols and good clinical practices (GCP) guidelines.

Explore the Largest Inventory of COVID-19 Research Samples.
Let's come together to strengthen COVID-19 research globally! Central BioHub offers a large stock of COVID-19 biospecimens sourced from suspected and clinically confirmed patients exclusively for research and development.
Resolving all the potential glitches and risks in COVID-19 research, Central BioHub offers a plethora of well-annotated, accurately screened, and well-preserved human biospecimens such as serum, plasma, oropharyngeal and nasopharyngeal secretions collected and stored in word class biobanks across the globe. Besides, you can also procure human serum and plasma samples obtained from individuals vaccinated with different FDA-approved COVID-19 vaccines. Every biosample can be ordered online through the most innovative human biospecimen marketplace without hassle. Hurry up, click here to explore the COVID-19 inventory of Central BioHub: https://centralbiohub.de/biospecimens/COVID-19

Our company was founded by a group of scientists, who were confronted with the time-consuming process of human biospecimen procurement. Our experiences have motivated us to develop an online marketplace, that connects people in the life science sector who need human biological samples and the suppliers who offer them.